Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2023 | Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4 | NATURE COMMUNICATIONS |